Pancreatic Cancer Research

ResearcherRoswell Park Comprehensive Cancer CenterNo recent work listed

Junhui Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0000-7148-3095; OpenAlex author ID A5100369267. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
22
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: 2 papers · 2021: none · 2022: 2 papers

Papers 7

  1. Small-Molecule MMRi62 Induces Ferroptosis and Inhibits Metastasis in Pancreatic Cancer via Degradation of Ferritin Heavy Chain and Mutant p53. Co-author DOI 10.1158/1535-7163.mct-21-0728↗
  2. Autophagic Schwann cells promote perineural invasion mediated by the NGF/ATG7 paracrine pathway in pancreatic cancer. Last author DOI 10.1186/s13046-021-02198-w↗
  3. Magnolol Suppresses Pancreatic Cancer Development In Vivo and In Vitro via Negatively Regulating TGF-β/Smad Signaling. Co-author DOI 10.3389/fonc.2020.597672↗
  4. The JAM-B/c-src/MMP9 pathway is associated with progression and regulates the invasion of pancreatic cancer. Last author DOI 10.7150/jca.40953↗
  5. High expression of microRNA-4295 contributes to cell proliferation and invasion of pancreatic ductal adenocarcinoma by the down-regulation of Glypican-5. Co-author DOI 10.1016/j.bbrc.2018.02.023↗
  6. Interaction of the sympathetic nerve with pancreatic cancer cells promotes perineural invasion through the activation of STAT3 signaling. Co-author DOI 10.1158/1535-7163.mct-12-0809↗
  7. Role of glial cell line-derived neurotrophic factor in perineural invasion of pancreatic cancer. Co-author DOI 10.1016/j.bbcan.2012.03.010↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wenbin Yang · 3 shared papers, 2018–2022 · strength 0.36
  2. Gang Cao · 3 shared papers, 2018–2020 · strength 0.34
  3. Wunai Zhang · 2 shared papers, 2020–2022 · strength 0.26
  4. Qinggong Yuan · 2 shared papers, 2018–2022 · strength 0.24
  5. Shuo Chen · 2 shared papers, 2020 · strength 0.23
  6. Dhyan Chandra · 1 shared paper, 2022 · strength 0.16
  7. Xinjiang Wang · 1 shared paper, 2022 · strength 0.16
  8. Tao Shan · 2 shared papers, 2013–2020 · strength 0.15
  9. Simei Zhang · 1 shared paper, 2022 · strength 0.13
  10. Zeen Zhu · 1 shared paper, 2022 · strength 0.13
  11. Weifan Zhang · 1 shared paper, 2022 · strength 0.13
  12. Shuo Chen · 1 shared paper, 2022 · strength 0.13
  13. Zheng Wang · 1 shared paper, 2022 · strength 0.13
  14. Li Zhang · 1 shared paper, 2020 · strength 0.13
  15. Yang Liu · 1 shared paper, 2020 · strength 0.11
  16. Jiaqi Shen · 1 shared paper, 2020 · strength 0.11
  17. Qingyong Ma · 2 shared papers, 2012–2013 · strength 0.07
  18. Qinhong Xu · 2 shared papers, 2012–2013 · strength 0.07
  19. Kun Guo · 1 shared paper, 2013 · strength 0.04
  20. Keping Xie · 1 shared paper, 2013 · strength 0.04
  21. Han Liu · 1 shared paper, 2012 · strength 0.04
  22. Xuqi Li · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.